The upregulation of CDCA8 has been reported in diverse types of cancer, including colorectal, breast, gastric, and lung cancer, implying that inhibition of CDCA8 expression could be an effective therapeutic strategy [14,25,26]. This evidence concerns the gene CDCA8 and cancer.